On April 24, 2024, Cidara Therapeutics, Inc. closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.59 USD | -0.79% | +5.18% | -22.04% |
May. 15 | Earnings Flash (CDTX) CIDARA THERAPEUTICS Posts Q1 Revenue $8.5M | MT |
May. 15 | Cidara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.04% | 57.89M | |
+14.28% | 118B | |
+12.94% | 106B | |
-3.62% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.01% | 15.56B | |
+4.22% | 13.63B | |
+27.59% | 12.27B |
- Stock Market
- Equities
- CDTX Stock
- News Cidara Therapeutics, Inc.
- Cidara Therapeutics, Inc. announced that it has received $240 million in funding from RA Capital Management, L.P., Canaan Management, Inc., BVF Partners L.P. and other investors